Total trials
68
Active
6
Phase 3
2
Total enrollment
100,197
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Inhaled Cannabis | — | — | — | — | — | 1 | |
| Intranasal Opioid | — | — | — | — | — | 1 |
Next readouts
- 2029-07-30
Top conditions
- Obesity4
- Breast Cancer3
- Cocaine Use Disorder3
- Stroke3
- Depression2
- Prostate Cancer2
- Critical Illness2
- Muscle Weakness2
Frequently asked questions about University of Kentucky
- How many clinical trials does University of Kentucky have on ClinicalTrials.gov?
- University of Kentucky is listed as the lead sponsor on 68 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Kentucky's trials are in Phase 3?
- 2 of University of Kentucky's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does University of Kentucky focus on?
- University of Kentucky's most-studied conditions on ClinicalTrials.gov are Obesity, Breast Cancer, Cocaine Use Disorder, Stroke, Depression.
- When are University of Kentucky's next clinical trial readouts?
- University of Kentucky has 1 upcoming primary-completion readout tracked here; the soonest is “Cannabis and Opioid Use Disorder, Study 2”, expected around 2029-07-30.